inhaled corticosteroid therapy

DRUG2 trials

Sponsors

Novartis, Oregon Health and Science University

Conditions

Bronchial AsthmaBronchiectasis

Phase 1

A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

CompletedNCT00411567

NovartisBronchial Asthma

Start: 2006-07-31Target: 26Updated: 2007-06-22

Unknown Phase

Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

CompletedNCT02714283

Oregon Health and Science UniversityBronchiectasis

Start: 2016-10-28End: 2018-07-01Updated: 2019-09-18